Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety

Table 3 Postoperative care at ICU

Variable	Control (number = 49)	EPO (number = 49)	P value
Crystalloid infused (ml)
at ICU POD 0	2795 ± 994	3045 ± 1054	0.231
at ICU POD 1	2380 ± 695	2261 ± 861	0.452
Colloid infused (ml)
at ICU POD 0	280 (100 to 500)	150 (0 to 500)	0.139
at ICU POD 1	0 (0 to 0)	0 (0 to 0)	0.317
Urine output (ml)
at ICU POD 0	2,180 ± 701	2,389 ± 832	0.182
at ICU POD 1	2,520 ± 722	2,628 ± 537	0.401
pRBCs transfused (ml)
at ICU POD 0	223 ± 344	222 ± 601	0.987
at ICU POD 1	63 ± 182	44 ± 136	0.555
Chest tube drainage (ml)
at ICU POD 0	390 (195 to 580)	330 (195 to 595)	0.394
at ICU POD 1	240 (165 to 375)	270 (180 to 440)	0.153
Patients transfused with pRBCs (number) at POD 0 and 1	16 (33)	23 (47)	0.149
Patients treated with vasopressors (number) at POD 0 and 1	18 (37)	12 (25)	0.188
Patients treated with inotropics (number) at POD 0 and 1	21 (43)	17 (35)	0.407

Values are mean ± SD or median (25th to 75th). ACC, aorta cross clamp; CPB, cardiopulmonary bypass; EPO, erythropoietin; POD, postoperative day; pRBCs, packed red blood cells.

ISSN: 1364-8535